Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach

NCT05295992 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscle-Invasive Bladder Carcinoma

Interventions

DEVICE: Varian Ethos Adaptive Radiation Therapy

Sponsor

Varian, a Siemens Healthineers Company

Collaborators

[object Object]
[object Object]